Research News
Hoth Therapeutics, Inc. has entered into a sponsored research agreement with GW to explore the potential use of Aprepitant for topical and/or systemic therapy to counter the dermatological related side-effects of Erlotinib therapy in cancer patients.
A recent survey found patients with psoriasis frequently use complementary or alternative therapies to treat their symptoms.
Cherinne Arundel, MD; Gurusher Panjrath, MD; Charles Faselis, MD; Richard M. Allman, MD; and Ali Ahmed, MD, MPH, all of SMHS, authored a study finding that patients with heart failure who have a systolic blood pressure less than 130 mmHg are at a higher…
Sanjay B. Maggirwar, PhD, MBA, has been selected to serve as chair of the Department of Microbiology, Immunology, and Tropical Medicine at the GW School of Medicine and Health Sciences.
Students in the Institute of Biomedical Sciences were hooded at the GW Columbian College School of Arts and Sciences Doctoral Hooding Ceremony.
Matthew Colonnese, PhD, has been awarded more than $4 million for the study of early brain activity.
The Accreditation Committee of the College of American Pathologists has awarded accreditation to the GW Biorepository based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.
Aileen Chang, MD, MSPH, will deliver a pitch during CureAccelerator Live! for the Developing World.
Two studies published by Andrew Meltzer, MD, associate professor of emergency medicine at SMHS, focus on improving physicians’ abilities to perform rapid diagnostics for patients in the emergency department.
Researchers from the GW Institute for Neuroscience published a new study in Neuron, which provides the first evidence showing that individual nerve cells fail to make the right number of connections. The reason for this deficit is limited growth of key nerve cells in the cerebral cortex during…